Qualigen Therapeutics faces Nasdaq delisting due to late filing of its 2024 Form 10-K but plans to appeal. Quiver AI Summary. Qualigen Therapeutics, Inc. announced that it received a deficiency ...

SINGAPORE, April 29, 2025 (GLOBE NEWSWIRE) -- JOYY Inc. (NASDAQ: JOYY) (“JOYY” or the “Company”), a global technology company, today announced that it filed its annual report on Form 20-F ...

Looking back on semiconductor manufacturing stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including FormFactor (NASDAQ:FORM) and its peers. The semiconductor ...

As previously reported, the Company’s delay in filing its 2024 Form 20-F is due to the fact that the finalization of the audit of the Company’s financial statements for the year ended December ...

The full Form 10 and additional investor materials are available on the SEC and DuPont Investor Relations websites. Friday, DD closed at $65.69, down 0.55%, and is trading after hours at $65.67, a ...

Marin Software Incorporated (NASDAQ: ... The Company does not expect to appeal Nasdaq’s determinations and expects Nasdaq to file a Form 25-NSE (Notification of Removal from Listing) ...

FormFactor, Inc. (NASDAQ: FORM), is a leading provider of essential test and measurement technologies along the full semiconductor product life cycle - from characterization, modeling, reliability ...